This article is part of the supplement: Lupus 2012: New targets, new approaches
Which lupus trial endpoints best reflect clinical judgment or biomarker improvement?
Arthritis Research & Therapy 2012, 14(Suppl 3):A47 doi:10.1186/ar3981
- Last 30 days: 50 accesses
- Last 365 days: 443 accesses
- All time: 895 accesses
These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information